Pre-Clinical Imaging (In-Vivo) Market : Report Summary and Scope
The global
pre-clinical imaging (in-vivo) market is growing significantly due to
development of high resolution and sensitive imaging devices with various
applications in the industry. Massive unexplored market in pre-clinical imaging
(in-vivo) industry of developing economies are creating ample opportunities for
the pre-clinical imaging (in-vivo) market to grow at a considerable rate in the
coming years. Further, technological advancement in pre-clinical imaging will
support the growth of the global pre-clinical imaging (in-vivo) market in the
coming years.
Pre-clinical (in-vivo) imaging is bridging a gap between the
vivo clinical research and vitro exploratory. It is increasingly being deployed
across the drug development process, specifically in oncology therapeutic area.
The advanced research and development facilities and new product developments
of the companies are supporting the growth of pre-clinical imaging (in-vivo)
industry. Moreover, integration of pre-clinical MRI systems with other imaging
modalities is also expected to propel the growth of the global pre-clinical
imaging market in coming years.
Request to Get the Sample Pages at:
Geographically, North America will be leading the global
pre-clinical imaging (in-vivo) market in the coming years due to high volume
pre-clinical research, entrenched infrastructure to conduct pre-clinical
research, rising government funding, and easy availability and accessibility of
resources. Asia-Pacific is the fastest growing region in the global
pre-clinical imaging (in-vivo) market; attributing to the growth are factors
such as increasing government funding for development of pharmaceutical
companies, and rising research and development activities by pharmaceutical and
biotechnology companies in the region. Moreover, the pre-clinical imaging
(in-vivo) market is growing due to increasing number of contract research
organizations in the emerging countries, such as India and China, of
Asia-Pacific region.
Some of the companies operating in the pre-clinical imaging
(in-vivo) market are Perkinelmer Inc., Mr Solutions Ltd., Mediso Ltd., Bruker
Corporation, Trifoil Imaging, Fujifilm Visualsonics Inc., Biospace Lab S.A.,
Milabs B.V., Li-Cor Biosciences, Thermo Fisher Scientific, Agilent Technologies
and Aspect Imaging.
Comments
Post a Comment